NothingMuch/GO-Terms huggingface dataset:
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
cross presentation
cross-presentation
exogenous peptide antigen processing and presentation via MHC class I, TAP-independent
TAP-independent antigen processing and presentation of exogenous peptide antigen via MHC class I
TAP-independent exogenous peptide antigen processing and presentation via MHC class I
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
exogenous peptide antigen processing and presentation via MHC class Ib, TAP-dependent
TAP-dependent antigen processing and presentation of exogenous peptide antigen via MHC class Ib
TAP-dependent exogenous peptide antigen processing and presentation via MHC class Ib
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
exogenous peptide antigen processing and presentation via MHC class Ib, TAP-independent
TAP-independent antigen processing and presentation of exogenous peptide antigen via MHC class Ib
TAP-independent exogenous peptide antigen processing and presentation via MHC class Ib
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
endogenous peptide antigen processing and presentation via MHC class I via ER pathway, TAP-dependent
TAP-dependent antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway
TAP-dependent endogenous peptide antigen processing and presentation via MHC class I via ER pathway
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-independent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following transport from the cytosol via a TAP-independent pathway. Class I here refers to classical class I molecules.
endogenous peptide antigen processing and presentation via MHC class I via ER pathway, TAP-independent
TAP-independent antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway
TAP-independent endogenous peptide antigen processing and presentation via MHC class I via ER pathway
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in an endolysosome. Class I here refers to classical class I molecules.
endogenous peptide antigen processing and presentation via MHC class I via endolysosomal pathway
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
endogenous peptide antigen processing and presentation via MHC class Ib via ER pathway, TAP-dependent
TAP-dependent antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway
TAP-dependent endogenous peptide antigen processing and presentation via MHC class Ib via ER pathway
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
endogenous peptide antigen processing and presentation via MHC class Ib via ER pathway, TAP-independent
TAP-independent antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway
TAP-independent endogenous peptide antigen processing and presentation via MHC class Ib via ER pathway
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
endogenous peptide antigen processing and presentation via MHC class II
The hydrolysis of a peptide bond or bonds within a protein by ER resident proteases contributing to antigen processing and presentation.
endoplasmic reticulum proteolysis associated with antigen processing and presentation
ER proteolysis associated with antigen processing and presentation
proteolysis within ER associated with antigen processing and presentation
The hydrolysis of a peptide bond or bonds within a protein by endosomal resident proteases contributing to antigen processing and presentation.
endosomal proteolysis associated with antigen processing and presentation
The hydrolysis of a peptide bond or bonds within a protein by lysosomal resident proteases contributing to antigen processing and presentation.
lysosomal proteolysis associated with antigen processing and presentation
Receptor editing occurring in B cells in the bone marrow.
central B lymphocyte receptor editing
central B-cell receptor editing
central B-lymphocyte receptor editing
Tolerance induction of T cells in the thymus.
central T lymphocyte tolerance induction
central T-cell tolerance induction
central T-lymphocyte tolerance induction
An increase in the internal diameter of blood vessels, especially arterioles or capillaries, usually resulting in a decrease in blood pressure contributing to an acute inflammatory response.
vasodilation during acute inflammatory response
Any process that modulates the extent to which blood vessels can be pervaded by fluid contributing to an acute inflammatory response.
regulation of vascular permeability during acute inflammatory response
Any process that modulates the force with which blood travels through the circulatory system that contributes to the acute phase response. The acute phase response occurs during the early phases of an infection and is marked by changes in the production of plasma proteins such as C-reactive protein.
blood pressure regulation during acute phase response
regulation of systemic arterial blood pressure during acute phase response
Any process that modulates the frequency, rate or extent of heart contraction that contributes to the acute phase response. The acute phase response occurs during the early phases of an infection and is marked by changes in the production of plasma proteins such as C-reactive protein.
regulation of cardiac contraction during acute phase response
regulation of heart contraction during acute phase response
The regulated release of lysosomal enzymes by a cell as part of an inflammatory response.
lysosomal enzyme secretion involved in acute inflammatory response
secretion of lysosomal enzymes involved in acute inflammatory response
secretion of lysosomal enzymes involved in inflammatory response
The synthesis or release of nitric oxide following a stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
nitric oxide production involved in acute inflammatory response
production of nitric oxide involved in acute inflammatory response
production of nitric oxide involved in inflammatory response
The synthesis or release of any prostaglandin following a stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
prostaglandin production involved in acute inflammatory response
Any process that activates Factor XII (Hageman factor). Factor XII is a protein synthesized by the liver that circulates in an inactive form until it encounters collagen or basement membrane or activated platelets (as occurs at the site of endothelial injury). Factor XII then undergoes a conformational change (becoming factor XIIa), exposing an active serine center that can subsequently cleave protein substrates and activate a variety of mediator systems. Factor XII is a participant in the clotting cascade as well as the kinin cascade.
Hageman factor activation
Any process that initiates the clotting cascade of blood coagulation, a cascade of plasma enzymes that is triggered following damage to blood vessels, leading to formation of a clot.
activation of clotting cascade
Any process that stops, prevents, or reduces the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
down regulation of tissue kallikrein-kinin cascade
down-regulation of tissue kallikrein-kinin cascade
downregulation of tissue kallikrein-kinin cascade
inhibition of tissue kallikrein-kinin cascade
negative regulation of glandular kallikrein-kinin cascade
Any process that activates or increases the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
activation of tissue kallikrein-kinin cascade
positive regulation of glandular kallikrein-kinin cascade
stimulation of tissue kallikrein-kinin cascade
up regulation of tissue kallikrein-kinin cascade
up-regulation of tissue kallikrein-kinin cascade
upregulation of tissue kallikrein-kinin cascade
Any process that stops, prevents, or reduces the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
down regulation of plasma kallikrein-kinin cascade
down-regulation of plasma kallikrein-kinin cascade
downregulation of plasma kallikrein-kinin cascade
inhibition of plasma kallikrein-kinin cascade
Any process that activates or increases the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
activation of plasma kallikrein-kinin cascade
stimulation of plasma kallikrein-kinin cascade
up regulation of plasma kallikrein-kinin cascade
up-regulation of plasma kallikrein-kinin cascade
upregulation of plasma kallikrein-kinin cascade
The regulated release of serotonin by a mast cell or group of mast cells.
serotonin release by mast cell
The regulated release of serotonin by a platelet or group of platelets.
serotonin release by platelet
The regulated release of serotonin by a basophil or group of basophils.
serotonin release by basophil
The generation of alternate transcripts of immunoglobulin genes through alternate splicing of exons.
alternate splicing of antibody genes
The addition of variable numbers of random nucleotides by terminal deoxytransferase in the N regions of heavy chain immunoglobulin genes. N regions are found at the V-D and D-J recombinational junctions.
somatic diversification of antibody genes by N region addition
The addition of variable numbers of random nucleotides by terminal deoxytransferase in the N regions of T cell receptor genes. N regions are found at the V-D, D-D, V-J, and D-J recombinational junctions, depending on the T cell receptor gene.
somatic diversification of TCR genes by N region addition
Any process that stops, prevents, or reduces the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class II.
down regulation of antigen processing and presentation of peptide antigen via MHC class II
down-regulation of antigen processing and presentation of peptide antigen via MHC class II
downregulation of antigen processing and presentation of peptide antigen via MHC class II
inhibition of antigen processing and presentation of peptide antigen via MHC class II
negative regulation of peptide antigen processing and presentation via MHC class II
Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class II.
activation of antigen processing and presentation of peptide antigen via MHC class II
positive regulation of peptide antigen processing and presentation via MHC class II
stimulation of antigen processing and presentation of peptide antigen via MHC class II
up regulation of antigen processing and presentation of peptide antigen via MHC class II
up-regulation of antigen processing and presentation of peptide antigen via MHC class II
upregulation of antigen processing and presentation of peptide antigen via MHC class II
Any process that stops, prevents, or reduces the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class Ib.
down regulation of antigen processing and presentation of peptide antigen via MHC class Ib
down-regulation of antigen processing and presentation of peptide antigen via MHC class Ib
downregulation of antigen processing and presentation of peptide antigen via MHC class Ib
inhibition of antigen processing and presentation of peptide antigen via MHC class Ib
negative regulation of peptide antigen processing and presentation via MHC class Ib
Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation of peptide antigen via MHC class Ib.
activation of antigen processing and presentation of peptide antigen via MHC class Ib
positive regulation of peptide antigen processing and presentation via MHC class Ib
stimulation of antigen processing and presentation of peptide antigen via MHC class Ib
up regulation of antigen processing and presentation of peptide antigen via MHC class Ib
up-regulation of antigen processing and presentation of peptide antigen via MHC class Ib
upregulation of antigen processing and presentation of peptide antigen via MHC class Ib
Any process that stops, prevents, or reduces the frequency, rate, or extent of antigen processing and presentation of lipid antigen via MHC class Ib.
down regulation of antigen processing and presentation of lipid antigen via MHC class Ib
down-regulation of antigen processing and presentation of lipid antigen via MHC class Ib
downregulation of antigen processing and presentation of lipid antigen via MHC class Ib
inhibition of antigen processing and presentation of lipid antigen via MHC class Ib
negative regulation of lipid antigen processing and presentation via MHC class Ib
Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation of lipid antigen via MHC class Ib.
activation of antigen processing and presentation of lipid antigen via MHC class Ib
positive regulation of lipid antigen processing and presentation via MHC class Ib
stimulation of antigen processing and presentation of lipid antigen via MHC class Ib
up regulation of antigen processing and presentation of lipid antigen via MHC class Ib
up-regulation of antigen processing and presentation of lipid antigen via MHC class Ib
upregulation of antigen processing and presentation of lipid antigen via MHC class Ib
Any process that stops, prevents, or reduces the frequency, rate, or extent of antigen processing and presentation of polysaccharide antigen via MHC class II.
down regulation of antigen processing and presentation of polysaccharide antigen via MHC class II
down-regulation of antigen processing and presentation of polysaccharide antigen via MHC class II
downregulation of antigen processing and presentation of polysaccharide antigen via MHC class II
inhibition of antigen processing and presentation of polysaccharide antigen via MHC class II
negative regulation of polysaccharide antigen processing and presentation via MHC class II
Any process that activates or increases the frequency, rate, or extent of antigen processing and presentation of polysaccharide antigen via MHC class II.
activation of antigen processing and presentation of polysaccharide antigen via MHC class II
positive regulation of polysaccharide antigen processing and presentation via MHC class II
stimulation of antigen processing and presentation of polysaccharide antigen via MHC class II
up regulation of antigen processing and presentation of polysaccharide antigen via MHC class II
up-regulation of antigen processing and presentation of polysaccharide antigen via MHC class II
upregulation of antigen processing and presentation of polysaccharide antigen via MHC class II
Any process that stops, prevents, or reduces the frequency, rate, or extent of myeloid dendritic cell antigen processing and presentation.
down regulation of myeloid dendritic cell antigen processing and presentation
down-regulation of myeloid dendritic cell antigen processing and presentation
downregulation of myeloid dendritic cell antigen processing and presentation
inhibition of myeloid dendritic cell antigen processing and presentation
Any process that activates or increases the frequency, rate, or extent of myeloid dendritic cell antigen processing and presentation.
activation of myeloid dendritic cell antigen processing and presentation
stimulation of myeloid dendritic cell antigen processing and presentation
up regulation of myeloid dendritic cell antigen processing and presentation
up-regulation of myeloid dendritic cell antigen processing and presentation
upregulation of myeloid dendritic cell antigen processing and presentation
Any process that stops, prevents, or reduces the frequency, rate, or extent of plasmacytoid dendritic cell antigen processing and presentation.
down regulation of plasmacytoid dendritic cell antigen processing and presentation
down-regulation of plasmacytoid dendritic cell antigen processing and presentation
downregulation of plasmacytoid dendritic cell antigen processing and presentation
inhibition of plasmacytoid dendritic cell antigen processing and presentation
Any process that activates or increases the frequency, rate, or extent of plasmacytoid dendritic cell antigen processing and presentation.
activation of plasmacytoid dendritic cell antigen processing and presentation
stimulation of plasmacytoid dendritic cell antigen processing and presentation
up regulation of plasmacytoid dendritic cell antigen processing and presentation
up-regulation of plasmacytoid dendritic cell antigen processing and presentation
upregulation of plasmacytoid dendritic cell antigen processing and presentation
Any process that stops, prevents, or reduces the frequency, rate, or extent of monocyte antigen processing and presentation.
down regulation of monocyte antigen processing and presentation
down-regulation of monocyte antigen processing and presentation
downregulation of monocyte antigen processing and presentation
inhibition of monocyte antigen processing and presentation
Any process that activates or increases the frequency, rate, or extent of monocyte antigen processing and presentation.
activation of monocyte antigen processing and presentation
stimulation of monocyte antigen processing and presentation
up regulation of monocyte antigen processing and presentation
up-regulation of monocyte antigen processing and presentation
upregulation of monocyte antigen processing and presentation
Any process that stops, prevents, or reduces the frequency, rate, or extent of macrophage antigen processing and presentation.
down regulation of macrophage antigen processing and presentation
down-regulation of macrophage antigen processing and presentation
downregulation of macrophage antigen processing and presentation
inhibition of macrophage antigen processing and presentation
Any process that activates or increases the frequency, rate, or extent of macrophage antigen processing and presentation.
activation of macrophage antigen processing and presentation
stimulation of macrophage antigen processing and presentation
up regulation of macrophage antigen processing and presentation
up-regulation of macrophage antigen processing and presentation
upregulation of macrophage antigen processing and presentation
Any process that stops, prevents, or reduces the frequency, rate, or extent of non-professional antigen presenting cell antigen processing and presentation.
down regulation of non-professional antigen presenting cell antigen processing and presentation
down-regulation of non-professional antigen presenting cell antigen processing and presentation
downregulation of non-professional antigen presenting cell antigen processing and presentation
inhibition of non-professional antigen presenting cell antigen processing and presentation
Any process that activates or increases the frequency, rate, or extent of non-professional antigen presenting cell antigen processing and presentation.
activation of non-professional antigen presenting cell antigen processing and presentation
stimulation of non-professional antigen presenting cell antigen processing and presentation
up regulation of non-professional antigen presenting cell antigen processing and presentation
up-regulation of non-professional antigen presenting cell antigen processing and presentation
upregulation of non-professional antigen presenting cell antigen processing and presentation
Any process that stops, prevents, or reduces the frequency, rate, or extent of B cell antigen processing and presentation.
down regulation of B cell antigen processing and presentation
down-regulation of B cell antigen processing and presentation
downregulation of B cell antigen processing and presentation
inhibition of B cell antigen processing and presentation
negative regulation of B lymphocyte antigen processing and presentation
negative regulation of B-cell antigen processing and presentation
negative regulation of B-lymphocyte antigen processing and presentation
Any process that activates or increases the frequency, rate, or extent of B cell antigen processing and presentation.
activation of B cell antigen processing and presentation
positive regulation of B lymphocyte antigen processing and presentation
positive regulation of B-cell antigen processing and presentation
positive regulation of B-lymphocyte antigen processing and presentation
stimulation of B cell antigen processing and presentation
up regulation of B cell antigen processing and presentation
up-regulation of B cell antigen processing and presentation
upregulation of B cell antigen processing and presentation